News
Midodrine may be comparable to albumin for PICD prevention in ACLF
- Author:
- Neil Osterweil
Given the small size of the open-label study, with only 25 patients in each arm, the results should be considered as proof of concept and need to...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Messier_Stephen_NC_web_0.jpg)
Randomized trial finds community-based weight-loss programs ease knee OA pain
- Author:
- Neil Osterweil
Participants who dieted and exercised in a community-based randomized trial had reductions in knee pain at 18 months; controls also improved...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Ozen_Gulsen_NEB_web.jpg)
Opioids increase risk for all-cause deaths in RA vs. NSAIDs
- Author:
- Neil Osterweil
The incidence of all-cause mortality was higher for patients with rheumatoid arthritis who started on opioids rather than NSAIDs for pain control...
News
![](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Prednisone, colchicine equivalent in efficacy for CPP crystal arthritis
- Author:
- Neil Osterweil
In an open-label, randomized trial, one in five patients on colchicine had diarrhea, tipping the safety scales in favor of prednisone.
News
Steroids and G-CSF improve 90-day survival in severe alcoholic hepatitis
- Author:
- Neil Osterweil
In addition to its superior results on the primary endpoint of 90-day survival, combination therapy was associated with significantly better...
News
![](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Retention rates high after biosimilar-to-biosimilar switch for inflammatory arthritis
- Author:
- Neil Osterweil
Danish investigators studied how a government-mandated switch from one infliximab biosimilar to another affected patients with inflammatory...
News
![](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
First recommendations for cancer screening in myositis issued
- Author:
- Neil Osterweil
The guideline, based on data from a systematic review and meta-analysis and on consensus from an international team of experts and patients,...
News
World falls short on HBV, HCV elimination targets
- Author:
- Neil Osterweil
“As countries progress toward eliminating hepatitis B and C, we really need to do more to expand political will and financing of national...
News
Resmetirom reduces liver, CV risk factors in NASH with cirrhosis
- Author:
- Neil Osterweil
“I do think it could be one of the drugs that really improves outcomes for patients with NASH.”
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Miller_Matthew_J_MICH_web.jpg)
NAFLD progresses to cirrhosis in young and old at similar rate
- Author:
- Neil Osterweil
Risk factors for NAFLD vary with age, but all patients experience similar progression of advanced disease once it develops.
News
![](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
High-quality index colonoscopies pay off down the road for low-risk patients
- Author:
- Neil Osterweil
Later risk for advanced adenomas, serrated polyps, or colorectal cancer was lower for patients with an initial high-quality colonoscopy.
News
Easier bowel prep recipe yields real-world results
- Author:
- Neil Osterweil
A reduced-volume bowel prep formulation was safe and was associated with high rates of adequate or better cleansing in a large practice-based...
News
Some young CRC patients are missing out on genetic counseling, testing
- Author:
- Neil Osterweil
Genetic counseling and testing of patients under 50 with CRC have improved over the last decade, but about 20% of patients still don’t get...
News
EUS-guided RF ablation doubles survival for unresectable pancreatic cancer
- Author:
- Neil Osterweil
Endoscopic ultrasound–guided radiofrequency ablation of tumors improved overall survival compared with standard of care.
News
Mucus unplugged
- Author:
- Neil Osterweil
Investigators seek balance between preserving mucus’s protective function and reducing oversecretion in inflammatory lung diseases.